Result
€54,297 €54,297
Back in profit in 2025, after a loss of €68,345 in 2024.
APOTHEEK VOS
Lifetime
17 annual accounts with figures on one time axispeak €345,182 (2015)
€278,083▲ 55.2%
lowest -€68,345 (2024)
€54,297▲ €122,642
peak €476,864 (2023)
€462,817▲ 13.3%
€913,644▼ 6.8%
peak 2.5 FTE (2016)
2.3 FTE▲ 15.0%
Board2 names since 2021
-
Owners
100%Hassotheek
Documentsfilings and deeds
15-06-202646 days before the deadline
2025abbreviated format
Gross margin from €179,189 to €278,083Back to profit: €54,297Staff from 2 FTE to 2.3 FTEEquity from €408,520 to €462,817Cash from €131,733 to €213,608
Key points
from the 2025 annual accountsChecked score
95
Excellent
Financially stronger than 60% of micro companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,273 companies (NACE 47, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.4%
01-2025: 0.4%● unchanged vs 12-2024
02-2025: 0.4%● unchanged vs 01-2025
03-2025: 0.4%● unchanged vs 02-2025
04-2025: 0.4%● unchanged vs 03-2025
05-2025: 0.5%▲ +0.1 percentage points vs 04-2025
06-2025: 0.6%▲ +0.1 percentage points vs 05-2025highest value
07-2025: 0.5%▼ -0.1 percentage points vs 06-2025
08-2025: 0.5%● unchanged vs 07-2025
09-2025: 0.5%● unchanged vs 08-2025
10-2025: 0.5%● unchanged vs 09-2025
11-2025: 0.3%▼ -0.2 percentage points vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.4%▲ +0.1 percentage points vs 05-2026
07-2026: 0.1%▼ -0.3 percentage points vs 06-2026lowest value
08-2026: 0.1%● unchanged vs 07-2026lowest value
09-2026: 0.1%● unchanged vs 08-2026lowest value
10-2026: 0.1%● unchanged vs 09-2026lowest value
11-2026: 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
lowers risk
Liquidity: current ratio 3.83, cash €213,608
Founded in 2009
Figures for financial year 2025 (filed on 15-06-2026)
Size: 2.3 FTE, total assets €1.4m
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 49% of them on solvency, 76% on liquidity, 52% on profitability and 65% on growth.
The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 10,904 companies had the same profile as APOTHEEK VOS has now. Each dot stands for 28 companies, two years later.
95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of APOTHEEK VOS itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 10,904 companies, not a prediction for APOTHEEK VOS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.83 (2.82 in 2024), above the usual 1.5. Short-term debt is 10.1% and cash 15.5% of total assets. However, 66.4% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-06-2026, 46 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
46 days early
2024
37 days early
2023
27 days late
2022
7 days early
2021
51 days early
2020
53 days early
2019
39 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 18 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
last known board- Hassotheek 100%equity €133,045 (2025) · 30-06-2025 annual accounts of Hassotheek
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0809237643
Registered office moved within Hasselt
New registered office: Vrijwilligersplein 6, 3500 Hasselt · Previous registered office: Vrijwilligersplein 8, 3500 Hasselt · Resignation: HASSOTHEEK (manager) · General meeting of 27-09-2023 · Gazette deed
1 director appointed, 1 resignation
Resignation: Dirk Vos · Appointment: Hassotheek NV · Permanent representative: Dirk Vos · General meeting of 31-03-2021 · Gazette deed
Environmental permit refused
Verbouwen en/of uitbreiden zonder functiewijziging en zonder wijziging van aantal woongelegenheden · Hasselt
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| APOTHEEK VOS Hasselt | €1.4m | €278,083 | 33.6% | 2.3 |
| G & PHarma Halen | €1.2m | €275,713 | 50.3% | 2.1 |
| DE LA DREVE Waterloo | €1.4m | €312,374 | 25.9% | 2.6 |
| VANDAELE PHARMA Aalter | €1.4m | €254,969 | 23.5% | 1.9 |
| Apotheek Breugelhof Tienen | €1.3m | €230,121 | 8.6% | 2.4 |
| Apotheek Ampe Middelkerke Middelkerke | €1.2m | €265,426 | 47.3% | 2.2 |
| Apotheek Van Damme C. Veurne | €1.3m | €321,932 | 63.1% | 2.3 |
These companies have the same main activity as APOTHEEK VOS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.2m and €1.4m, founded between 2006 and 2012.
Official details
Source: KBO- Status
- Active since 21-01-2009Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2024
- Establishment unit
- 2.175.587.5613500 Hasselt, since 21-01-2009
- Financial year end
- 31 December
- Peppol
- Reachable since 27-06-2025
Annual accounts 2025
- ≈ €1.0mestimated
- €1.4m▼ 0.9%
- Employeeson 31-12-2025
- 3▲ 50.0%
- Filing
- Filed on 15-06-2026, 46 days before the end of the filing period
Insights on APOTHEEK VOS
APOTHEEK VOS files the abbreviated format. That format states no turnover. The gross margin rose from €122,561 in 2009 to €278,083 in 2025.
The balance sheet grew most from 2020 to 2022 through fixed assets.
Hassotheek holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about APOTHEEK VOS
- What is the company number of APOTHEEK VOS?
- The company number of APOTHEEK VOS is 0809.237.643. The VAT number is the same number with BE in front: BE 0809.237.643.
- Where is APOTHEEK VOS based?
- The registered office is at Vrijwilligersplein 6, 3500 Hasselt.Company details
- What does APOTHEEK VOS do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK VOS?
- APOTHEEK VOS is a private limited company (BV).
- When was APOTHEEK VOS founded?
- APOTHEEK VOS was founded on 21-01-2009.
- Is APOTHEEK VOS still active?
- Yes, APOTHEEK VOS is an active enterprise in the KBO register.
- How many employees does APOTHEEK VOS have?
- APOTHEEK VOS had an average of 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK VOS fall under?
- In its 2024 annual accounts, APOTHEEK VOS states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of APOTHEEK VOS?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €278,083 and 48 comparable companies (NACE 477). It probably lies between €760,000 and €1.7m. In financial year 2022 turnover was €1.4m.
- Is APOTHEEK VOS profitable?
- In financial year 2025, APOTHEEK VOS made a profit of €54,297.
- Where can I find the annual accounts of APOTHEEK VOS?
- APOTHEEK VOS filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK VOS due?
- APOTHEEK VOS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.